Request Demo
Last update 08 May 2025
Tibet Haisco Pharmaceutical Co. Ltd.
Subsidiary Company|2019|Xizang Zizhiqu, China
Subsidiary Company|2019|Xizang Zizhiqu, China
Last update 08 May 2025
Overview
Basic Info
Introduction Tibet Haisco Pharmaceutical Co. Ltd. is a subsidiary of Haisco Pharmaceutical Group Co., Ltd. and operates as a pharmaceutical and healthcare services provider based in China. |
Tags
Neoplasms
Other Diseases
Urogenital Diseases
Small molecule drug
Chemical drugs
Recombinant polypeptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20250251
一项在既往未接受过补体抑制剂治疗的阵发性睡眠性血红蛋白尿症患者中评价HSK39297片的有效性和安全性的多中心、随机、开放、阳性对照Ⅲ期临床研究
[Translation] A multicenter, randomized, open-label, positive-controlled phase III clinical study to evaluate the efficacy and safety of HSK39297 tablets in patients with paroxysmal nocturnal hemoglobinuria who had not previously received complement inhibitor treatment
CTR20250383
评估HSK39004吸入粉雾剂在健康受试者中的安全性、耐受性和药代动力学特征的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of HSK39004 inhalation powder in healthy subjects
CTR20244670
一项评价 HSK39297 片在阵发性睡眠性血红蛋白尿症患者中的 长期安全性和有效性的多中心、开放 II 期临床研究
[Translation] A multicenter, open-label phase II clinical study to evaluate the long-term safety and efficacy of HSK39297 tablets in patients with paroxysmal nocturnal hemoglobinuria
100 Clinical Results associated with Tibet Haisco Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Tibet Haisco Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Tibet Haisco Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 30 May 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
7
8
Preclinical
IND Application
1
7
Phase 1 Clinical
Phase 2 Clinical
3
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free